Fluid Intake Application to Reduce Kidney Stone Risks
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01928108|
Recruitment Status : Completed
First Posted : August 23, 2013
Last Update Posted : March 28, 2017
|Condition or disease||Intervention/treatment|
|Kidney Stone||Behavioral: iPhone Application Behavioral: Android Application|
|Study Type :||Observational|
|Actual Enrollment :||10 participants|
|Official Title:||Do Different Methods of Educating Patients Regarding Fluid Intake Reduce Kidney Stone Risks?|
|Study Start Date :||July 2013|
|Actual Primary Completion Date :||March 1, 2017|
|Actual Study Completion Date :||March 16, 2017|
Participants using an iPhone will download the "waterlogged" application and use this to track daily water intake for 1 week.
Behavioral: iPhone Application
The iPhone application "waterlogged" will be used by participants using and iPhone cellular device. This application will be used to track daily fluid intake for 1 week.
Participants using an Android cell phone will download the "water your body" application and use this to track daily water intake for 1 week.
Behavioral: Android Application
The Android application "water my body" will be used by participants using an Android cellular device. This application will be used to track daily fluid intake for 1 week.
- 24-hour urine volume [ Time Frame: 7-10 days from baseline ]
- Actual 24-hour urine volume vs. patient perceived urine volume [ Time Frame: 7-10 days from baseline ]
- Ease and interest in monitoring fluid intake based on survey data [ Time Frame: 7-10 days from baseline ]
- 24-hour urine volume for study participants vs. urine volume for retrospective cohort of previously treated kidney stone patients [ Time Frame: 7-10 days from baseline ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01928108
|United States, North Carolina|
|North Carolina Memorial Hospital|
|Chapel Hill, North Carolina, United States, 27599|
|Principal Investigator:||Davis Viprakasit, MD||University of North Carolina, Chapel Hill|